20 results on '"Mazeron MC"'
Search Results
2. Opportunistic agents in bronchoalveolar lavage in 99 HIV seropositive patients
- Author
-
Durand-Amat, S, primary, Zalcman, G, additional, Mazeron, MC, additional, Sarfati, C, additional, Beauvais, B, additional, Gerber, F, additional, Perol, Y, additional, and Hirsch, A, additional
- Published
- 1990
- Full Text
- View/download PDF
3. Automated quantification of Epstein-Barr virus in whole blood for post-transplant lymphoproliferative disorders monitoring.
- Author
-
Salmona M, Stefic K, Mahjoub N, de Fontbrune FS, Maylin S, Simon F, Scieux C, Socié G, Mazeron MC, and LeGoff J
- Subjects
- Automation, Laboratory, DNA, Viral blood, Epstein-Barr Virus Infections blood, Humans, Limit of Detection, Lymphoproliferative Disorders prevention & control, Prospective Studies, Real-Time Polymerase Chain Reaction, Retrospective Studies, Sensitivity and Specificity, Blood virology, Epstein-Barr Virus Infections diagnosis, Hematopoietic Stem Cell Transplantation adverse effects, Herpesvirus 4, Human isolation & purification, Lymphoproliferative Disorders virology, Viral Load methods
- Abstract
Background: Standardized and sensitive assays for Epstein Barr Virus (EBV) are needed to define universal cutoff for treatment initiation in allogeneic hematopoietic stem cells transplant recipients. In a context of accreditation and the availability of EBV international standard, we evaluated the Abbott RealTime EBV (RT) assay for EBV quantification in whole blood., Methods: The RT assay was compared on 282 prospective clinical samples with the Artus EBV PCR Kit V1 assay (V1) and we analyzed the kinetics of EBV load in 11 patients receiving rituximab treatment., Results: The estimated limit of detection was 88 IU/mL. The assay was linear (r
2 = 0.9974) in the range of all samples tested (100 to 1,000,000 IU/mL). Intra-assay coefficients of variation (CV) ranged between 0.35 and 1.35%, and inter-assay CV between 3.40 and 4.5%. On samples above the limit of quantification, the two assays were strongly correlated. EBV RT values were on average 0.30 log10 IU/mL lower than those measured with the V1 assay. In patients treated with rituximab, the RT assay remained positive in 5 patients at the time it dropped below undetectable levels with the V1 assay., Conclusions: In conclusion, the RT assay is a reliable assay for EBV load in whole blood. Its sensitivity will enable to estimate the kinetics of EBV load and the impact of treatments to control EBV reactivations.- Published
- 2020
- Full Text
- View/download PDF
4. Multimodal techniques failed to detect cytomegalovirus in human glioblastoma samples.
- Author
-
Loit MP, Adle-Biassette H, Bouazza S, Mazeron MC, Manivet P, Lehmann-Che J, Teissier N, Mandonnet E, and Molina JM
- Subjects
- Adult, Aged, Aged, 80 and over, Brain Neoplasms immunology, Brain Neoplasms mortality, Brain Neoplasms surgery, Cytomegalovirus drug effects, Cytomegalovirus genetics, Cytomegalovirus Infections immunology, Cytomegalovirus Infections mortality, Cytomegalovirus Infections surgery, DNA, Viral genetics, Female, Glioblastoma immunology, Glioblastoma mortality, Glioblastoma surgery, Humans, Immunohistochemistry, In Situ Hybridization, Male, Middle Aged, Real-Time Polymerase Chain Reaction, Retrospective Studies, Seroepidemiologic Studies, Steroids administration & dosage, Steroids adverse effects, Survival Analysis, Virus Activation drug effects, Antibodies, Viral blood, Brain Neoplasms virology, Cytomegalovirus immunology, Cytomegalovirus Infections virology, DNA, Viral blood, Glioblastoma virology
- Abstract
The role of the human cytomegalovirus (HCMV) in gliomagenesis is largely debated. Contradictory data exist regarding the sensitivity and specificity of HCMV detection techniques, including immunohistochemistry (IHC), in situ hybridization (ISH), and RNA and DNA sequencing. The aim of this study is to detect HCMV in glioblastoma (GBM) tumor samples using IHC, ISH, and real-time PCR (qPCR), as well as to correlate the findings with serological status and HCMV DNA load in blood. Forty-seven patients with histopathological diagnosis of GBM and HCMV serological status were retrospectively reviewed. HCMV DNA quantification in whole blood was performed in 31 patients. The detection of HCMV in tumor samples was performed using IHC in 42 cases, ISH in 10 cases, and qPCR in 29 cases. All but two patients were taking high steroid doses at the time of biological testing. HCMV seroprevalence was 68%. Active infection with HCMV DNA detected in blood was diagnosed in 6 out of 21 (28%) seropositive patients. HCMV was not detected in GBM samples using IHC or ISH, while qPCR was positive in one case (also positive for blood HCMV DNA). These data do not support a crucial role of HCMV in GBM tumorigenesis. HCMV might be reactivated in GBM patients, due to steroid treatment.
- Published
- 2019
- Full Text
- View/download PDF
5. What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSM.
- Author
-
Bendenoun M, Samri A, Avettand-Fènoël V, Cardinaud S, Descours B, Carcelain G, Mazeron MC, Bergmann JF, Urrutia A, Moris A, Rouzioux C, Simon F, Andre P, Pocard M, Dray X, Mourez T, Vieillard V, Autran B, Barin F, and Sellier P
- Subjects
- Adult, HIV Infections genetics, HIV Infections immunology, HIV Infections virology, HIV-1 physiology, Humans, Male, Phylogeny, T-Lymphocytes immunology, Genetic Background, Homosexuality, Male genetics, Sexual Partners
- Abstract
Background: We describe a homosexual man who strongly controlled HIV-1 for ten years despite lack of protective genetic background., Methods: HIV-1 DNA was measured in blood and other tissues. Cell susceptibility was evaluated with various strains. HIV-1-specific (CD4 and CD8 activation markers and immune check points) and NK cells responses were assessed; KIRs haplotypes and HLA alleles were determined., Findings: Two HIV-1 RNA copies/mL of plasma were detected in 2009, using an ultra-sensitive assay. HIV-DNA was detected at 1.1 and 2 copies/10
6 PBMCs in 2009 and 2015 respectively, at 1.2 copies/106 cells in rectal cells in 2011. WBs showed weak reactivity with antibodies to gp160, p55 and p25 from 2007 to 2014, remaining incomplete in 2017. CD4 T cells were susceptible to various strains including HIVKON , a primary isolate of his own CRF02_AG variant. CD8 T cells showed a strong poly-functional response against HIV-Gag, producing mainly IFN-γ; a robust capacity of antibody-dependant cell cytotoxicity (ADCC) was observed in NK cells. Case patient was group B KIR haplotype. Neutralizing antibodies were not detected. CD4 and CD8 blood T cells showed normal proportions without increased activation markers. Phylogenetic analyses identified the same CRF02_AG variant in his partner. The patient and his partner were heterozygous for the CCR5ΔD32 deletion and shared HLA-B*07, C*07 non-protective alleles., Interpretation: This thorough description of the natural history of an individual controlling HIV-1 in various compartments for ten years despite lack of protective alleles, and of his partner, may have implications for strategies to cure HIV-1 infection., (Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF
6. Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status.
- Author
-
Servais S, Dumontier N, Biard L, Schnepf N, Resche-Rigon M, Peffault de Latour R, Scieux C, Robin M, Meunier M, Xhaard A, Sicre de Fontbrune F, Le Goff J, Socié G, Simon F, and Mazeron MC
- Subjects
- Adolescent, Adult, Aged, Child, DNA, Viral, Drug Resistance, Viral, Female, Follow-Up Studies, Graft vs Host Disease etiology, Humans, Male, Middle Aged, Treatment Outcome, Viral Load, Young Adult, Antiviral Agents therapeutic use, Cytomegalovirus physiology, Cytomegalovirus Infections drug therapy, Cytomegalovirus Infections virology, Hematopoietic Stem Cell Transplantation adverse effects, Tissue Donors, Transplant Recipients, Virus Activation
- Abstract
Pre-emptive antiviral treatment efficiently prevents occurrence of cytomegalovirus (CMV) disease in allogeneic stem cell transplant recipients. However, successive treatment courses can be necessary. The current study was aimed at determining factors that could influence the response to antiviral treatment, in particular the donor CMV serostatus. A total of 147 consecutive CMV-seropositive recipients (R+) were included and prospectively monitored for 6 months after transplantation. Reactivation of CMV occurred in 111 patients, 61 of 78 with a CMV-positive donor (D+) and in 50 of 69 with a CMV-negative donor (D-) (p 0.45). Baseline viral loads and initial viral doubling times did not differ between D+/R+ and D-/R+. Fifteen D+/R+ and four D-/R+ had self-resolving CMV infections. A total of 92 patients received antiviral treatment and 81 (88%) had a significant decrease in CMV load under therapy. Repeated CMV episodes were observed in 67% of those and were significantly more frequent in D-/R+ than in D+/R+ (p <0001). Half-life of CMV under treatment was significantly longer in D-/R+ than in D+/R+. Treatment failure observed in eight recipients was associated with low leucocyte count at reactivation onset, and was significantly more frequent in D-/R+ (six patients) than in D+/R+ (two patients) (p <0.0001). CMV strains resistant to antivirals were found in two D-/R+. Donor CMV serostatus influenced neither CMV reactivation occurrence nor the kinetics of CMV DNA load in the early phase of CMV replication but had a significant impact on response to antiviral therapy. Virological drug-resistance remained rare., (Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
7. Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation.
- Author
-
Kheav VD, Busson M, Scieux C, Peffault de Latour R, Maki G, Haas P, Mazeron MC, Carmagnat M, Masson E, Xhaard A, Robin M, Ribaud P, Dulphy N, Loiseau P, Charron D, Socié G, Toubert A, and Moins-Teisserenc H
- Subjects
- Adolescent, Adult, Chronic Disease, Cytomegalovirus Infections pathology, Cytomegalovirus Infections virology, Female, Flow Cytometry, Follow-Up Studies, Graft vs Host Disease etiology, Hematologic Neoplasms mortality, Hematologic Neoplasms therapy, Humans, Lymphocyte Subsets immunology, Male, Neoplasm Staging, Prognosis, Prospective Studies, Survival Rate, Transplantation Conditioning, Transplantation, Homologous, Virus Activation immunology, Young Adult, Cytomegalovirus immunology, Cytomegalovirus Infections immunology, Graft vs Host Disease prevention & control, Hematologic Neoplasms complications, Hematopoietic Stem Cell Transplantation adverse effects, Killer Cells, Natural immunology
- Abstract
Natural killer cells are the first lymphocyte subset to reconstitute, and play a major role in early immunity after allogeneic hematopoietic stem cell transplantation. Cells expressing the activating receptor NKG2C seem crucial in the resolution of cytomegalovirus episodes, even in the absence of T cells. We prospectively investigated natural killer-cell reconstitution in a cohort of 439 adult recipients who underwent non-T-cell-depleted allogeneic hematopoietic stem cell transplantation between 2005 and 2012. Freshly collected blood samples were analyzed 3, 6, 12 and 24 months after transplantation. Data were studied with respect to conditioning regimen, source of stem cells, underlying disease, occurrence of graft-versus-host disease, and profiles of cytomegalovirus reactivation. In multivariate analysis we found that the absolute numbers of CD56(bright) natural killer cells at month 3 were significantly higher after myeloablative conditioning than after reduced intensity conditioning. Acute graft-versus-host disease impaired reconstitution of total and CD56(dim) natural killer cells at month 3. In contrast, high natural killer cell count at month 3 was associated with a lower incidence of chronic graft-versus-host disease, independently of a previous episode of acute graft-versus-host disease and stem cell source. NKG2C(+)CD56(dim) and total natural killer cell counts at month 3 were lower in patients with reactivation of cytomegalovirus between month 0 and month 3, but expanded greatly afterwards. These cells were also less numerous in patients who experienced later cytomegalovirus reactivation between month 3 and month 6. Our results advocate a direct role of NKG2C-expressing natural killer cells in the early control of cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation., (Copyright© Ferrata Storti Foundation.)
- Published
- 2014
- Full Text
- View/download PDF
8. Hepatitis B virus (HBV) status of children born to HIV/HBV co-infected women in a French hospital: a cross-sectional study.
- Author
-
Sellier P, Schnepf N, Amarsy R, Maylin S, Coutellier M, Lopes A, Mazeron MC, Flateau C, Morgand M, Ciraru-Vigneron N, Berthe A, Ricbourg A, Dolores-Moreno AM, Simoneau G, Evans J, Souak S, Matheron S, Mouly S, Benifla JL, Simon F, and Bergmann JF
- Abstract
Introduction: Human Immunodeficiency Virus (HIV) Mother-To-Child-Transmission (MTCT) and prevention by combined antiretroviral therapy (cART) have been extensively studied. Hepatitis B Virus (HBV) MTCT from HIV/HBV co-infected women and prevention by antiretroviral therapy with dual activity have been poorly studied. The aim of the study was to assess HBV MTCT from HIV/HBV co-infected women in a developed country with a large access to cART., Materials and Methods: HIV/HBV co-infected pregnant women attending the Obstetrics Department from 1st January 2000 to 1st January 2012 could be included in the study (NCT02044068). Antiretroviral therapy during pregnancy, injection of immunoglobulin and/or vaccine to newborns was retrospectively recorded. We assessed HBV status of children at least as old as two years., Results: Forty nine (9.2%) from 530 HIV-infected women followed in the hospital were HIV/HBV co-infected. 34 (69.4%) had given birth to 57 children in the hospital. 13 of these women (22 children) were lost-to-follow-up, 21 women (35 children) could be studied. Twenty six children (74.3%) had HBs Ab at a protective level, 22 of them had received immunoglobulin at birth; 24 had received a complete vaccine schedule during the first six months of life (with immunoglobulin in 21 cases). The women had been given lamivudine or tenofovir/emtricitabine during eight and nine pregnancies respectively. Eight children (22.8%) were tested negative for HBs Ag, HBs Ab and HBc Ab: 4 (11.4%) had received immunoglobulin and a complete vaccine schedule; in two children, immunoglobulin was uncertain; in one child, the vaccine schedule was incomplete; in the last one, data about immunoglobulin and the vaccine schedule were lacking. The women had been given lamivudine or tenofovir/emtricitabine during five and two pregnancies respectively. One child had HBc Ab and HBs Ab, immunoglobulin was uncertain and the vaccine schedule was incomplete. The woman had been given lamivudine during the last trimester., Conclusions: Three quarters of the children were protected. HBs Ab were negative in more than a tenth of the children who had received immunoglobulin and a complete vaccine schedule, questioning on long-term protection and underlining the need of control.
- Published
- 2014
- Full Text
- View/download PDF
9. Fully automated quantification of cytomegalovirus (CMV) in whole blood with the new sensitive Abbott RealTime CMV assay in the era of the CMV international standard.
- Author
-
Schnepf N, Scieux C, Resche-Riggon M, Feghoul L, Xhaard A, Gallien S, Molina JM, Socié G, Viglietti D, Simon F, Mazeron MC, and Legoff J
- Subjects
- Automation, Laboratory methods, Cytomegalovirus genetics, Humans, Reproducibility of Results, Sensitivity and Specificity, Specimen Handling methods, Viral Load standards, Blood virology, Cytomegalovirus isolation & purification, Molecular Diagnostic Techniques methods, Viral Load methods
- Abstract
Fully standardized reproducible and sensitive quantification assays for cytomegalovirus (CMV) are needed to better define thresholds for antiviral therapy initiation and interruption. We evaluated the newly released Abbott RealTime CMV assay for CMV quantification in whole blood (WB) that includes automated extraction and amplification (m2000 RealTime system). Sensitivity, accuracy, linearity, and intra- and interassay variability were validated in a WB matrix using Quality Control for Molecular Diagnostics (QCMD) panels and the WHO international standard (IS). The intra- and interassay coefficients of variation were 1.37% and 2.09% at 5 log10 copies/ml and 2.41% and 3.80% at 3 log10 copies/ml, respectively. According to expected values for the QCMD and Abbott RealTime CMV methods, the lower limits of quantification were 104 and <50 copies/ml, respectively. The conversion factor between international units and copies (2.18), determined from serial dilutions of the WHO IS in WB, was significantly different from the factor provided by the manufacturer (1.56) (P = 0.001). Results from 302 clinical samples were compared with those from the Qiagen artus CMV assay on the same m2000 RealTime system. The two assays provided highly concordant results (concordance correlation coefficient, 0.92), but the Abbott RealTime CMV assay detected and quantified, respectively, 20.6% and 47.8% more samples than the Qiagen/artus CMV assay. The sensitivity and reproducibility of the results, along with the automation, fulfilled the quality requirements for implementation of the Abbott RealTime CMV assay in clinical settings. Our results highlight the need for careful validation of conversion factors provided by the manufacturers for the WHO IS in WB to allow future comparison of results obtained with different assays.
- Published
- 2013
- Full Text
- View/download PDF
10. Can serum soluble CD23 or CD30 predict the occurrence of lymphoma in HIV-infected patients?
- Author
-
Jarrin I, Boval B, Mazeron MC, Simoneau G, Magnier JD, Green A, Andreoli A, Bergmann JF, and Sellier P
- Subjects
- Adult, Female, HIV Infections metabolism, Humans, Ki-1 Antigen genetics, Ki-1 Antigen metabolism, Male, Middle Aged, Receptors, IgE genetics, Receptors, IgE metabolism, HIV Infections complications, Ki-1 Antigen blood, Lymphoma, Non-Hodgkin etiology, Receptors, IgE blood
- Published
- 2011
- Full Text
- View/download PDF
11. Hepatitis E virus infection in HIV-infected patients with elevated serum transaminases levels.
- Author
-
Sellier P, Mazeron MC, Tesse S, Badsi E, Evans J, Magnier JD, Sanson-Le-Pors MJ, Bergmann JF, and Nicand E
- Subjects
- Adult, Antibody Affinity, Female, Hepatitis Antibodies blood, Hepatitis E virology, Humans, Immunoglobulin G blood, Immunoglobulin M blood, Male, Middle Aged, Molecular Sequence Data, Pakistan epidemiology, Prevalence, RNA, Viral blood, RNA, Viral genetics, Retrospective Studies, Sequence Analysis, DNA, HIV Infections complications, Hepatitis E epidemiology, Hepatitis E pathology, Hepatitis E virus immunology, Hepatitis E virus isolation & purification, Transaminases blood
- Abstract
Increases in aminotransferases levels are frequently encountered in HIV-positive patients and often remain unexplained. The role in this setting and natural history of hepatitis E in HIV-infected patients are unknown. The aim of the study was to assess HEV infection in HIV-infected patients attending a Parisian hospital, with a current or previous cryptogenic hepatitis.191 plasma samples collected from 108 HIV-infected patients with elevated aminotransferases levels were retrospectively tested for the presence of hepatitis E virus (HEV) infection markers: anti-HEV IgM antibodies, anti-HEV IgG antibodies, anti-HEV IgG avidity index and plasma HEV RNA.One acute infection, documented by positive tests for anti-HEV IgM antibody, low anti-HEV IgG avidity index and plasma HEV RNA (genotype 3e), and three past infections were diagnosed, without any observed case of persistent infection. The acute hepatitis was benign and resolved spontaneously within two weeks. This infection was probably contracted locally. Acute HEV hepatitis can occur in HIV-infected patients but rarely explains cryptogenic hepatitis, at least in an urban HIV population, regardless geographic origin and CD4 counts.
- Published
- 2011
- Full Text
- View/download PDF
12. Early selection of a new UL97 mutant with a severe defect of ganciclovir phosphorylation after valaciclovir prophylaxis and short-term ganciclovir therapy in a renal transplant recipient.
- Author
-
Hantz S, Michel D, Fillet AM, Guigonis V, Champier G, Mazeron MC, Bensman A, Denis F, Mertens T, Dehee A, and Alain S
- Subjects
- Acyclovir therapeutic use, Adolescent, Antiviral Agents therapeutic use, Chemoprevention, Codon, Cytomegalovirus genetics, Cytomegalovirus Infections drug therapy, Cytomegalovirus Infections virology, Ganciclovir metabolism, Ganciclovir therapeutic use, Humans, Molecular Sequence Data, Phosphorylation, Valacyclovir, Valine therapeutic use, Acyclovir analogs & derivatives, Antiviral Agents pharmacology, Cytomegalovirus drug effects, Drug Resistance, Viral genetics, Ganciclovir pharmacology, Kidney Transplantation adverse effects, Phosphotransferases (Alcohol Group Acceptor) genetics, Sequence Deletion, Valine analogs & derivatives
- Abstract
We describe the emergence of a new ganciclovir resistance mutation in the UL97 gene of human cytomegalovirus, deletion of codon 601, after valaciclovir and short-term ganciclovir therapy following kidney transplantation. Its role in ganciclovir resistance was supported by decreased ganciclovir phosphorylation in a recombinant vaccinia virus system.
- Published
- 2005
- Full Text
- View/download PDF
13. A prospective assessment of cytomegalovirus infection in active inflammatory bowel disease.
- Author
-
de Saussure P, Lavergne-Slove A, Mazeron MC, Alain S, Matuchansky C, and Bouhnik Y
- Subjects
- Administration, Oral, Adolescent, Adult, Aged, Aged, 80 and over, Antibodies, Viral analysis, Cohort Studies, Cytomegalovirus immunology, Cytomegalovirus isolation & purification, Female, Glucocorticoids administration & dosage, Humans, Immunoglobulin G analysis, Immunoglobulin M analysis, Inflammatory Bowel Diseases drug therapy, Male, Middle Aged, Prospective Studies, Cytomegalovirus Infections, Inflammatory Bowel Diseases virology
- Abstract
Background: The prevalence and clinical significance of cytomegalovirus infection is reportedly high in patients with refractory inflammatory bowel disease but is unknown in unselected patients with active disease., Methods: In patients admitted for active inflammatory bowel disease, we prospectively studied the presence and significance of cytomegalovirus infection using anti-cytomegalovirus antibodies, cytomegalovirus viraemia and antigenaemia and cytomegalovirus inclusions and cytomegalovirus immunochemistry staining in ileocolonic biopsies., Results: A total of 64 patients were included (ulcerative colitis, n = 23; Crohn's disease, n = 41), 18 of whom had been on high-dose oral steroids and 11 on immunosuppressants. Anti-cytomegalovirus IgG and IgM were positive in 42 (66%) and 3 (5%) patients respectively. Blood or urine cytomegalovirus replication markers were found in 4 (6%) patients, all of whom had ulcerative colitis. Three patients had cytomegalovirus viraemia and received anti-viral treatment with ganciclovir. Only one of these patients had cytomegalovirus antigenaemia and also associated biopsy-proven cytomegalovirus colitis, probably as a primary cytomegalovirus infection. This patient is the only one who benefitted from anti-viral therapy., Conclusions: Cytomegalovirus infection is infrequent in in-patients with active inflammatory bowel disease. Systematic search of cytomegalovirus replication markers should not be performed. Isolated viraemia without associated antigenaemia or direct demonstration of cytomegalovirus in ileocolonic biopsies does not warrant anti-viral therapy.
- Published
- 2004
- Full Text
- View/download PDF
14. Natural polymorphism of cytomegalovirus DNA polymerase lies in two nonconserved regions located between domains delta-C and II and between domains III and I.
- Author
-
Fillet AM, Auray L, Alain S, Gourlain K, Imbert BM, Najioullah F, Champier G, Gouarin S, Carquin J, Houhou N, Garrigue I, Ducancelle A, Thouvenot D, and Mazeron MC
- Subjects
- Amino Acid Sequence, Amino Acid Substitution, Antiviral Agents pharmacology, Conserved Sequence, Cytomegalovirus drug effects, Gene Deletion, Humans, Molecular Sequence Data, Phenotype, Polymorphism, Genetic genetics, Reverse Transcriptase Polymerase Chain Reaction, Cytomegalovirus enzymology, Cytomegalovirus genetics, DNA-Directed DNA Polymerase genetics
- Abstract
We described the natural polymorphism of cytomegalovirus DNA polymerase in 42 unrelated isolates susceptible to ganciclovir, foscarnet, and cidofovir. All variations, including an eight-amino-acid deletion, were located between domains delta-C and II and between domains III and I, suggesting that these specific residues are not involved in enzymatic functions.
- Published
- 2004
- Full Text
- View/download PDF
15. Risk of cytomegalovirus transmission by cryopreserved semen: a study of 635 semen samples from 231 donors.
- Author
-
Bresson JL, Clavequin MC, Mazeron MC, Mengelle C, Scieux C, Segondy M, and Houhou N
- Subjects
- Antibodies, Viral analysis, Cytomegalovirus Infections diagnosis, Cytomegalovirus Infections prevention & control, Female, Humans, Immunoglobulin G analysis, Immunoglobulin M analysis, Male, Polymerase Chain Reaction, Prospective Studies, Quarantine, Risk Assessment, Serologic Tests methods, Time Factors, Cryopreservation, Cytomegalovirus Infections transmission, Semen virology, Tissue Donors
- Abstract
Background: The hypothetical responsibility of sperm donation in cytomegalovirus (CMV) transmission to recipients and precautions to prevent this transmission are widely discussed. The aim of this French CECOS Federation study was to evaluate both the reality and the importance of the CMV risk due to donor sperm and the relevance of measures used to screen it., Methods: We conducted a prospective multicentric study. CMV was detected by rapid and conventional cultures and by PCR in the frozen sperm of donors who met the normal criteria required of semen donors, irrespective of their CMV serological status., Results: 635 samples from 231 donors (39.4% IgG(+)) were obtained and tested by culture; 551 samples from 197 donors were also tested by PCR. From those samples, 0.78% were culture(+), 1.57% culture(+) and/or PCR(+); 3.3% of seropositive donors and 0.72% of initially seronegative donors were culture(+), but in the latter seroconversion occurred during the quarantine period; of the 197 PCR-tested donors, 3.5% (6.2/1.7) were PCR(+), 3.3% (5.3/1.45) culture(+) and/or PCR(+). PCR(+) samples can be culture(-) and vice versa. The most strongly positive sample corresponded to an initially seronegative donor., Conclusion: The best strategy to prevent potential CMV risk is to test donors for CMV IgG and IgM antibody at the outset and after a 6 month period of quarantine and to reject initially IgM seropositive donors or donors who seroconvert during the quarantine period.
- Published
- 2003
- Full Text
- View/download PDF
16. Quantitative markers for cytomegalovirus disease in HIV-infected patients receiving highly active antiretroviral therapy.
- Author
-
Mazeron MC, Fillet AM, Salmon D, Boukli N, Houhou N, Sénéchal B, Matheron S, Gozlan J, Leport C, Katlama C, Scieux C, Imbert BM, Deny P, Bour JB, Freymuth F, Chanzy B, Chaput S, and Costagliola D
- Subjects
- Biomarkers blood, HIV Infections drug therapy, Humans, Prospective Studies, AIDS-Related Opportunistic Infections diagnosis, Antiretroviral Therapy, Highly Active, Cytomegalovirus Infections diagnosis
- Published
- 2003
- Full Text
- View/download PDF
17. Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy.
- Author
-
Salmon-Céron D, Mazeron MC, Chaput S, Boukli N, Senechal B, Houhou N, Katlama C, Matheron S, Fillet AM, Gozlan J, Leport C, Jeantils V, Freymuth F, and Costagliola D
- Subjects
- AIDS-Related Opportunistic Infections epidemiology, AIDS-Related Opportunistic Infections immunology, AIDS-Related Opportunistic Infections virology, Adult, Aged, Cohort Studies, Cytomegalovirus immunology, Cytomegalovirus isolation & purification, Cytomegalovirus Infections epidemiology, Cytomegalovirus Infections immunology, Cytomegalovirus Infections virology, DNA, Viral blood, HIV Infections complications, HIV Infections immunology, HIV-1 physiology, Humans, Incidence, Middle Aged, Prognosis, Prospective Studies, Reverse Transcriptase Inhibitors therapeutic use, Risk Factors, Viral Load, AIDS-Related Opportunistic Infections etiology, Anti-HIV Agents therapeutic use, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, Cytomegalovirus Infections etiology, HIV Infections drug therapy, Phosphoproteins blood, Viral Matrix Proteins blood
- Abstract
Objective: To study the natural history and the current risk factors for cytomegalovirus (CMV) disease in the context of highly active antiretroviral therapy (HAART)., Setting: Prospective multicentre cohort in 15 university hospitals in France., Methods: A group of 198 patients with CD4 cell count < 100 x 10(6) cells/l (or < 200 x 10(6) cells/l under HAART for at least 2 months), no previous CMV disease and CMV-positive serology were followed every 4 months clinically and for virological testing including HIV RNA and CMV blood markers (culture, pp65 antigenaemia, plasma CMV DNA and CMV late mRNA by the polymerase chain reaction)., Results: At inclusion, median CD4 was 77 x 10(6) cells/l (0-308) and 85% of the patients received protease inhibitors. The percentage of patients receiving HAART reached 99% at 12 months. After a follow-up of 23.6 months, the incidence of CMV disease was 3.2/100 patient-years [95% confidence interval (CI) 1.3-5.0]. In univariate Cox models, all the CMV markers, a CD4 cell count remaining < 75 x 10(6) cells/l and an HIV viral load > 100,000 copies/ml were predictive for CMV disease. The hazard ratios for CMV disease were 11 for blood culture; 14 and 70 for pp65 antigenaemia of > or = 1 and > or = 100 nuclei/200,000 cells, respectively; 35 for plasma CMV DNA; 6 for CMV mRNA; 29 for CD4 < 75 x 10(6) cells/l; and 12 for HIV RNA > 100,000 copies/ml. In a stepwise multivariate analysis, only three covariates were independently associated with the occurrence of a disease: plasma CMV DNA, pp65 antigenaemia > or = 100 nuclei/200,000 cells and a CD4 count < 75 x 10(6) cells/l., Conclusion: CMV blood markers and CD4 count < 75 x 10(6) cells/l remain risk factors for CMV disease in patients receiving HAART. Analysis of plasma CMV DNA by the polymerase chain reaction is a reproducible and standardized tool that could be used as a decision marker for initiating CMV pre-emptive therapy.
- Published
- 2000
- Full Text
- View/download PDF
18. Monoclonal antibody E-13 (M-810) to human cytomegalovirus recognizes an epitope encoded by exon 2 of the major immediate early gene.
- Author
-
Mazeron MC, Jahn G, and Plachter B
- Subjects
- Antibody Specificity, Cloning, Molecular, Exons genetics, Genes, Viral genetics, Humans, Open Reading Frames genetics, Recombinant Fusion Proteins immunology, Antibodies, Monoclonal, Antibodies, Viral immunology, Antigens, Viral immunology, Cytomegalovirus immunology, Epitopes immunology, Immediate-Early Proteins
- Abstract
Monoclonal antibody (MAb) E-13 to human cytomegalovirus is used widely for diagnostic and fundamental studies, and has been shown to be directed against an immediate early (IE) protein(s). To determine which viral antigen is detected by MAb E-13, four subfragments from the open reading frame encoded by exons 2, 3 or 4 of IE-1 were cloned in the bacterial expression vector pROS. The resulting fusion proteins contained amino acids 77 to 491 encoded by mainly exon 4, amino acids 25 to 78 encoded by exon 3, amino acids 1 to 85 encoded by exons 2 and 3, and amino acids 1 to 24 encoded by exon 2. The reactivity of MAb E-13 with the fusion proteins was assayed by Western blotting. MAb E-13 was shown to react exclusively with proteins encoded by exon 2 and therefore recognizes IE proteins which contain the N-terminal amino acid sequence encoded by exon 2, namely the major 72K IE protein, the 82K to 86K IE-2 protein and the 52K to 55K IE-2 protein. MAb E-13 can be used to detect both IE-1- and IE-2-encoded proteins, which share the polypeptide encoded by exon 2.
- Published
- 1992
- Full Text
- View/download PDF
19. Comparative study of tissue culture and mouse inoculation methods for demonstration of Toxoplasma gondii.
- Author
-
Derouin F, Mazeron MC, and Garin YJ
- Subjects
- Animals, Antibodies, Protozoan analysis, Brain parasitology, Cells, Cultured, Female, Fibroblasts, Fluorescent Antibody Technique, Humans, Male, Mice, Toxoplasma immunology, Toxoplasma isolation & purification, Toxoplasmosis, Animal diagnosis
- Abstract
Two methods for the isolation of Toxoplasma gondii were analyzed and compared. Bradyzoites or tachyzoites of three strains of T. gondii were injected into mice and introduced in parallel onto MRC5 fibroblasts cultured on cover slips. In the cultures, the parasites were more readily identified by an indirect immunofluorescence assay than by examination of unstained or Giemsa-stained cultures. With the RH strain, the tachyzoites replicated actively, and large foci of parasites were observed in 24 h. The bradyzoites or tachyzoites of the other strains could also be cultivated, but grew rather slowly; 2 days after inoculation, early stages of multiplication could be observed: from day +4, Toxoplasma clusters or foci were easily identified at a x100 magnification. The course of infection in mice was greatly dependent on the virulence of the strain and on the parasitic stage inoculated. In the chronically infected mice, evidence of Toxoplasma infection was only detected 45 days after inoculation through the demonstration of cysts in the brain or the presence of specific antibodies in the serum. The mean ratio of infected mice and positive cultures was compared in relation to the inoculum size. The tissue culture method was found to be at least as sensitive as mouse inoculation. Since Toxoplasma organisms may be isolated within a few days in tissue culture, it is proposed that this method should be used when early isolation of the parasite is crucial for the diagnosis of toxoplasmosis.
- Published
- 1987
- Full Text
- View/download PDF
20. Rapid detection of human cytomegalovirus in the urine of humans.
- Author
-
Alpert G, Mazeron MC, Colimon R, and Plotkin S
- Subjects
- Antibodies, Monoclonal, Antibodies, Viral, Bone Marrow Transplantation, Child, Cytomegalovirus Infections urine, Fluorescent Antibody Technique, Humans, Infant, Kidney Transplantation, Urine immunology, Viral Plaque Assay, Antigens, Viral analysis, Cytomegalovirus growth & development, Cytomegalovirus immunology, Cytomegalovirus Infections diagnosis, Urine microbiology
- Published
- 1985
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.